Efficacy of Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Immunotherapy as Single Treatment for Patients With NSCLC With Brain Metastases: A Systematic Review and Meta-Analysis-the META-L-BRAIN Study
J Thorac Oncol 2021 Aug 01;16(8)1379-1391, V Teixeira Loiola de Alencar, MP Guedes Camandaroba, R Pirolli, CAZ Fogassa, VC Cordeiro de LimaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.